Steiger U, Lippuner K, Jensen E X, Montandon A, Jaeger P, Horber F F
Medizinische Universitätspoliklinik, University Hospital of Berne, Switzerland.
Eur J Clin Invest. 1995 Nov;25(11):809-16. doi: 10.1111/j.1365-2362.1995.tb01689.x.
Kidney transplant patients display decreased muscle mass and increased fat mass. Whether this altered body composition is due to glucocorticoid induced altered fuel metabolism is unclear. To answer this question, 16 kidney transplant patients were examined immediately after kidney transplantation (12 +/- 4 days, mean +/- SEM) and then during months 2, 5, 11 and 16, respectively, by whole body dual energy X-ray absorptiometry (Hologic QDR 1000W) and indirect calorimetry. Results were compared with those of 16 age, sex and body mass index matched healthy volunteers examined only once. All patients received dietary counselling with a step 1 diet of the American Heart Association and were advised to restrict their caloric intake to the resting energy expenditure plus 30%. Immediately after transplantation, lean mass of the trunk was higher by 7 +/- 1% (P < 0.05) and that of the limbs was lower by more than 10% (P < 0.01) in patients than in controls. In contrast, no difference in fat mass and resting energy expenditure could be detected between patients and controls. During the 16 months of observation, total fat mass increased in male (+4.9 +/- 1.5 kg), but not in female patients (0.1 +/- 0.8 kg). The change in fat mass observed in men was due to an increase in all subregions of the body analysed (trunk, arms+legs as well as head+neck), whereas in women only an increase in head+neck by 9 +/- 2% (P = 0.05) was detected. Body fat distribution remained unchanged in both sexes over the 16 months of observation. Lean mass of the trunk mainly decreased between days 11 and 42 (P < 0.01) and remained stable thereafter. After day 42, lean mass of arms and legs (mostly striated muscle) and head+neck progressively increased over the 14 months of observation by 1.6 +/- 0.6 kg (P < 0.05) and 0.4 +/- 0.1 kg (P < 0.01), respectively. Resting energy expenditure was similar in controls and patients at 42 days (30.0 +/- 0.7 vs. 31.0 +/- 0.9 kcal kg-1 lean mass) and did not change during the following 15 months of observation. However, composition of fuel used to sustain resting energy expenditure in the fasting state was altered in patients when compared with normal subjects, i.e. glucose oxidation was higher by more than 45% in patients (P < 0.01) during the second month after grafting, but gradually declined (P < 0.01) over the following 15 months to values similar to those observed in controls. Protein oxidation was elevated in renal transplant patients on prednisone at first measurement, a difference which tended to decline over the study period. In contrast to glucose and protein oxidation, fat oxidation was lower in patients 42 days after grafting (P < 0.01), but increased by more than 100% reaching values similar to those observed in controls after 16 months of study. Mean daily dose of prednisone per kg body weight correlated with the three components of fuel oxidation (r > 0.93, P < 0.01), i.e. protein, glucose and fat oxidation. These results indicate that in prednisone treated renal transplant patients fuel metabolism is regulated in a dose-dependent manner. Moreover, dietary measures, such as caloric and fat intake restriction as well as increase of protein intake, can prevent muscle wasting as well as part of the usually observed fat accumulation. Furthermore, the concept of preferential upper body fat accumulation as consequence of prednisone therapy in renal transplant patients has to be revised.
肾移植患者表现出肌肉量减少和脂肪量增加。这种身体成分的改变是否归因于糖皮质激素诱导的燃料代谢改变尚不清楚。为回答这个问题,对16例肾移植患者在肾移植后立即(12±4天,均值±标准误)进行检查,然后分别在第2、5、11和16个月时,通过全身双能X线吸收法(Hologic QDR 1000W)和间接测热法进行检查。将结果与16例年龄、性别和体重指数匹配的健康志愿者(仅检查一次)的结果进行比较。所有患者均接受了美国心脏协会第一步饮食的饮食咨询,并被建议将热量摄入限制在静息能量消耗加30%。移植后立即,患者躯干的瘦体重比对照组高7±1%(P<0.05),四肢的瘦体重比对照组低超过10%(P<0.01)。相比之下,患者和对照组之间的脂肪量和静息能量消耗没有差异。在16个月的观察期内,男性患者的总脂肪量增加(+4.9±1.5kg),而女性患者没有增加(0.1±0.8kg)。男性患者观察到的脂肪量变化是由于所分析身体的所有亚区域(躯干、手臂+腿部以及头部+颈部)均增加,而女性患者仅检测到头部+颈部增加9±2%(P=0.05)。在16个月的观察期内,两性的体脂分布均保持不变。躯干的瘦体重主要在第11天至42天之间下降(P<0.01),此后保持稳定。在第42天之后,手臂和腿部(主要是横纹肌)以及头部+颈部的瘦体重在14个月的观察期内逐渐增加,分别增加了1.6±0.6kg(P<0.05)和0.4±0.1kg(P<0.01)。对照组和患者在42天时的静息能量消耗相似(30.0±0.7与31.0±0.9kcal kg-1瘦体重),并且在随后15个月的观察期内没有变化。然而,与正常受试者相比,患者在禁食状态下用于维持静息能量消耗的燃料组成发生了改变,即移植后第二个月患者的葡萄糖氧化率高出45%以上(P<0.01),但在随后15个月中逐渐下降(P<0.01),降至与对照组相似的值。首次测量时,服用泼尼松的肾移植患者的蛋白质氧化率升高,在研究期间这种差异有下降趋势。与葡萄糖和蛋白质氧化相反,移植后42天患者的脂肪氧化率较低(P<0.01),但在16个月的研究后增加了100%以上,达到与对照组相似的值。每千克体重的泼尼松平均每日剂量与燃料氧化的三个成分(r>0.93,P<0.01),即蛋白质、葡萄糖和脂肪氧化相关。这些结果表明,在接受泼尼松治疗的肾移植患者中,燃料代谢以剂量依赖的方式受到调节。此外,饮食措施,如限制热量和脂肪摄入以及增加蛋白质摄入,可以预防肌肉消耗以及部分通常观察到的脂肪堆积。此外,肾移植患者中由于泼尼松治疗导致上半身优先脂肪堆积的概念必须修正。